$214 Profit
PTILong Stock
F12B

Entry comments: Catalyst> (FDA) has granted Breakthrough Therapy Designation for PTI-428, the Company’s cystic fibrosis transmembrane conductance regulator (CFTR) amplifier. Bought the dip.

Exit comments: This stock was a faster mover, and I was very nervous being in it. I am just aiming for singles. Thanks for the lessons Tim :)

110
DatePrice
Entry3/13/20186.14
Exit3/13/20186.751
  • Total Views71
  • Position Size350
  • Percentage9.95%
Proof
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
Join now or log in to leave a comment